Table 2.
Reactome pathways overrepresentation against whole human genome.
| Observed | Expected | Fold Enrichment | FDR | |
|---|---|---|---|---|
| Immune System (R-HSA-168256) | 16 | 2.62 | 6.11 | 2.89E-02 |
| Cytokine Signaling in Immune system (R-HSA-1280215) | 10 | 1.00 | 10.01 | 4.07E-07 |
| Hemostasis (R-HSA-109582) | 7 | .81 | 8.62 | 4.00E-02 |
| Innate Immune System (R-HSA-168249) | 7 | 1.34 | 5.22 | 5.17E-03 |
| Transcriptional Regulation by RUNX3 (R-HSA-8878159) | 4 | .11 | 35.43 | 4.43E-02 |
| Interferon Signaling (R-HSA-913531) | 4 | .24 | 16.81 | 2.49E-02 |
| Apoptosis (R-HSA-109581) | 4 | .21 | 19.27 | 3.60E-02 |
| Interferon Gamma Signaling (R-HSA-877300) | 3 | .11 | 27.16 | 1.51E-02 |
| Interleukin-4 and Interleukin-13 signaling (R-HSA-6785807) | 3 | .13 | 22.26 | 1.26E-02 |
| Transcriptional regulation by RUNX2 (R-HSA-8878166) | 3 | .14 | 21.12 | 4.27E-02 |
| Interleukin-27 Signaling (R-HSA-9020956) | 2 | .01 | >100 | 3.08E-03 |
| Interleukin-35 Signaling (R-HSA-8984722) | 2 | .01 | >100 | 2.36E-05 |
| IL-6-type Cytokine Receptor Ligand Interactions (R-HSA-6788467) | 2 | .02 | 96.92 | 1.56E-02 |
| Interleukin-20 Family Signaling (R-HSA-8854691) | 2 | .03 | 65.90 | 1.71E-02 |
| Antigen Presentation: Folding, Assembly and Peptide Loading of Class I MHC (R-HSA-983170) | 2 | .03 | 63.37 | 2.72E-02 |